Cancer Biogenesis in Ribosomopathies
Ribosomopathies are congenital diseases with defects in ribosome assembly and are characterized by elevated cancer risks. Additionally, somatic mutations in ribosomal proteins have recently been linked to a variety of cancers. Despite a clear correlation between ribosome defects and cancer, the mole...
Main Authors: | Sergey O. Sulima, Kim R. Kampen, Kim De Keersmaecker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4409/8/3/229 |
Similar Items
-
The Expanding Riboverse
by: Sergey O. Sulima, et al.
Published: (2019-10-01) -
Ribosomopathies: New Therapeutic Perspectives
by: Emilien Orgebin, et al.
Published: (2020-09-01) -
Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment
by: Mengxin Wang, et al.
Published: (2024-03-01) -
Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies
by: Christos I. Papagiannopoulos, et al.
Published: (2022-02-01) -
Ribosomopathies: how a common root can cause a tree of pathologies
by: Nadia Danilova, et al.
Published: (2015-09-01)